Skip to content
S8798Senate2021-2022 SessionSame asA9206

Disclose Step Therapy Data

Official title

“Relates to reporting information regarding step therapy override requests and determinations; repealer”

Sponsor Neil D. BreslinSD-44+1 co-sponsorAffects Finance
Status
In Senate Committee
Insurance
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires health plans to publicly report and disclose detailed information about step therapy override requests, determinations, and related protocols.

Why it matters

  1. Improves transparency for patients and providers. By requiring public, drug-specific reporting and online disclosure of step therapy override data and protocols, patients and healthcare professionals can better understand how and why certain medications might be subject to step therapy requirements and how often exceptions are granted or denied.

  2. Enables oversight of insurance practices. With annual reporting and public data on override requests (including approvals, denials, reasons for denial, and appeal outcomes), regulators, advocates, and researchers can more easily identify patterns of potentially unfair or burdensome insurer behavior, leading to stronger accountability.

  3. Mandates advance notice for changes in step therapy rules. Insurers and managed care organizations must notify affected patients and providers at least 60 days before implementing changes to step therapy protocols or clinical criteria, helping patients and physicians plan ahead for any impact on treatment access.

  4. Supports informed decision-making and advocacy. By making detailed, organized data readily available, the bill empowers patients, healthcare providers, and advocacy groups to challenge inappropriate step therapy practices, appeal denials more effectively, and push for reforms where step therapy may be impeding timely access to needed medications.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Health insurers, HMOs and utilization review agents

    The bill would require annual reporting and public disclosure of step therapy override requests, approvals, denials, denial reasons and internal appeal reversals by drug name, category and class.

  • Patients subject to step therapy

    Insured patients and HMO enrollees would gain access to protocols, appeal information and clinical review criteria, plus at least 60 days’ written notice of changes that may affect them.

  • Prescribers and other health care professionals

    They would receive access to step therapy rules and review criteria and at least 60 days’ written notice of changes that may affect them.

  • State insurance and health regulators

    They would set reporting and disclosure formats and receive annual data on step therapy override requests and outcomes, including the types or specialties of providers submitting requests.

Headline styles

Disclose Step Therapy Data

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 44

Chair, Insurance

1 Co-sponsor

History

  1. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9206Assembly

Disclose Step Therapy Overrides

In Assembly Committee · Insurance · Sponsor John T. McDonald III

Impact 4 · Low0% to pass

Full text

4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8798

IN SENATE

April 18, 2022

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law and the public health law, in relation to enhanced disclosure of step therapy override requests and determinations; and to repeal certain provisions of such laws relating thereto

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 4903 of the insurance law is amended by adding two new subsections (j) and (k) to read as follows:

(j) Each health care plan and utilization review agent shall annually, in such form as the superintendent shall require, report information to the department regarding step therapy override requests and determinations. Such reports shall, among other things, separately identify the following information, organized by individual drug name and drug category and class:

(1) The number of step therapy override determination requests received;

(2) The type of health care providers or the medical specialties of the health care providers submitting requests;

(3) The number of step therapy override determination requests that were initially denied and the reasons for such denials;

(4) The number of step therapy override determination requests that were initially approved; and

(5) The number of step therapy override determination requests that were reversed on internal appeal.

(k) Each health care plan and utilization review agent shall disclose, in such form as the superintendent shall require, non-confidential information regarding step therapy override requests and determinations on a website or web-based tool that is readily accessible to the public. Such disclosure shall, among other things, separately identify the following information, organized by individual drug name and drug category and class:

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14461-01-2

(1) The number of step therapy override determination requests received;

(2) The type of health care providers or the medical specialties of the health care providers submitting requests;

(3) The number of step therapy override determination requests that were initially denied and the reasons for such denials;

(4) The number of step therapy override determination requests that were initially approved; and

(5) The number of step therapy override determination requests that were reversed on internal appeal.

§ 2. Section 4903 of the public health law is amended by adding two new subdivisions 10 and 11 to read as follows:

10. Each health care plan and utilization review agent shall annually, in such form as the commissioner shall require, report information to the department regarding step therapy override determination requests and the outcomes of such requests. Such reports shall, among other things, separately identify the following information, organized by individual drug name and drug category and class:

(a) The number of step therapy override determination requests received;

(b) The type of health care providers or the medical specialties of the health care providers submitting requests;

(c) The number of step therapy override determination requests that were initially denied and the reasons for such denials;

(d) The number of step therapy override determination requests that were initially approved; and

(e) The number of step therapy override determination requests that were reversed on internal appeal.

11. Each health care plan and utilization review agent shall disclose, in such form as the commissioner shall require, non-confidential information regarding step therapy override requests and determinations on a website or web-based tool that is readily accessible to the public. Such disclosure shall, among other things, separately identify the following information, organized by individual drug name and drug category and class:

(a) The number of step therapy override determination requests received;

(b) The type of health care providers or the medical specialties of the health care providers submitting requests;

(c) The number of step therapy override determination requests that were initially denied and the reasons for such denials;

(d) The number of step therapy override determination requests that were initially approved; and

(e) The number of step therapy override determination requests that were reversed on internal appeal.

§ 3. Paragraph 10 of subsection (b) of section 3217-a of the insurance law is REPEALED and three new subsections (g), (h) and (i) are added to read as follows:

(g) Where applicable, each insurer subject to this article shall disclose information on step therapy protocols, step therapy override determinations, and internal and external appeals, as governed by article forty-nine of this chapter, and any associated clinical review criteria pertaining to specific conditions and diseases. Such information shall be made readily accessible on the insurer's website or webbased tool and, upon request, in written or electronic form to an insured or an insured's authorized representative and a health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter.

(h) If an insurer subject to this article intends either to implement a new requirement or restriction or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such insurer shall ensure that such new or amended requirement or restriction is not implemented unless such insurer's website or webbased tool has been updated to reflect such new or amended requirement or restriction.

(i) If an insurer subject to this article intends either to implement a new requirement or restriction, or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such insurer shall provide any insured or health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter who may be impacted by such new requirement, restriction, or amendment with written notice of such new requirement, restriction, or amendment no less than sixty days before implementation. Such notice may be delivered electronically or by other means.

§ 4. Paragraph 10 of subsection (b) of section 4324 of the insurance law is REPEALED and three new subsections (g), (h) and (i) are added to read as follows:

(g) Where applicable, each health service, hospital service, or medical indemnity corporation subject to this article shall disclose information on step therapy protocols, step therapy override determinations, and internal and external appeals, as governed by article forty-nine of this chapter, and any associated clinical review criteria pertaining to specific conditions and diseases. Such information shall be made readily accessible on such health service, hospital service, or medical indemnity corporation's website or web-based tool and, upon request, in written or electronic form to an insured or the insured's authorized representative and a health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter.

(h) If a health service, hospital service, or medical indemnity corporation subject to this article intends either to implement a new requirement or restriction or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such health service, hospital service, or medical indemnity corporation shall ensure that such new or amended requirement or restriction is not implemented unless such health service, hospital service, or medical indemnity corporation's website or web-based tool has been updated to reflect such new or amended requirement or restriction.

(i) If a health service, hospital service, or medical indemnity corporation subject to this article intends either to implement a new requirement or restriction or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such health service, hospital service, or medical indemnity corporation shall provide any insured or health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter who may be impacted by such new requirement, restriction, or amendment with written notice of such new requirement, restriction, or amendment no less than sixty days before implementation. Such notice may be delivered electronically or by other means.

§ 5. Paragraph (j) of subdivision 2 of section 4408 of the public health law is REPEALED and three new subdivisions 8, 9 and 10 and are added to read as follows:

8. Where applicable, each health maintenance organization subject to this article shall disclose information on step therapy protocols, step therapy override determinations, and internal and external appeals, as governed by article forty-nine of this chapter, and any associated clinical review criteria pertaining to specific conditions and diseases. Such information shall be made readily accessible on such health maintenance organization's website or web-based tool and, upon request, in written or electronic form to an enrollee or the enrollee's authorized representative and a health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter.

9. If a health maintenance organization subject to this article intends either to implement a new requirement or restriction or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such health maintenance organization shall ensure that such new or amended requirement or restriction is not implemented unless such health maintenance organization's website or webbased tool has been updated to reflect such new or amended requirement or restriction.

10. If a health maintenance organization subject to this article intends either to implement a new requirement or restriction or amend an existing requirement or restriction, relating to a step therapy protocol, internal or external step therapy appeals protocol, or associated clinical review criteria, such health maintenance organization shall provide any enrollee or health care professional as defined in subsection (f) of section four thousand nine hundred of this chapter who may be impacted by such new requirement, restriction, or amendment with written notice of such new requirement, restriction, or amendment no less than sixty days before implementation. Such notice may be delivered electronically or by other means.

§ 6. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law and the public health law, in relation to enhanced disclosure of step therapy override requests and determi- nations; and to repeal certain provisions of such laws relating thereto

Purpose or general idea of bill

The purpose of this bill is to require insurers and utilization review agents to report to the Department of Financial Services (DFS) and require insurers and certain health organizations to make publicly available certain information on step therapy override requests, appeals, and their outcomes.

Summary of provisions

Section one amends section 4903 of the insurance law to require each health care plan and utilization review agents to annually report infor- mation to DFS regarding step therapy override requests and determi- nations. The report must include, but is not limited to, the number of step therapy override determination requests. In addition, the report must include the type of health care providers submitting requests. The report must include the number of step therapy override determination requests that were initially denied and the reasons for such denials. The report must include the number of step therapy override determi- nation requests that were initially approved and the number of requests that were reversed upon appeal.

The utilization review agent is also required to disclose the same non- confidential information, listed above, in a form the Superintendent requires and must post on a readily accessible website.

Section two amends section 4903 of the public health law with the same requirements as section one.

Section three repeals section 3217-a of the insurance law and adds three new subsections. New subsection (g) requires each insurer subject to this article to disclose information on step therapy protocols, step therapy override determinations, internal and external appeals, and associated clinical review information on a publicly accessible website and upon request in written or electronic form. Subsection (h) requires such insurers to update their websites with information related to any new requirement or restrictions before implementation. Finally, subsection (i) requires such insurers to provide any insured or health care professional who may be impacted by any new requirements, restrictions, or amendments with written notice no less than 60 days before implementation.

Section four repeals subsection (b) of section 4324 of the insurance law and adds three new subsections similar to the amendments from section three. These disclosure requirements apply to each health service, hospital service, or medical indemnity corporation subject to this arti- cle.

Section five repeals subdivision two of section 4408 of the public health law and adds three new subdivisions similar to the amendments made in sections three and four of this bill. These disclosure require- ments apply to each health maintenance organization subject to this article.

Section six requires that this act shall take effect immediately.

Justification

Reporting requirements are essential to understand whether insurers are complying with the law. It also allows patients and providers equal access to information. Publication of step therapy data also provides the patients, health care professionals, and policymakers the opportu- nity to identify potential violations of the law and room for improve- ment.

Prior legislative history

New Bill

Fiscal implications

None

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.